Author:
Trenova Anastasiya G.,Slavov Georgi S.,Manova Maria G.,Aksentieva Jana B.,Miteva Lyuba D.,Stanilova Spaska A.
Abstract
Abstract
Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients. Cognitive dysfunctions impact significantly patients’ quality of life, independently from the course and phase of the disease.
The relationship between pathological brain findings and cognitive impairment is a subject of intensive research.
Summarizing recent data about prevalence, clinical specificity and treatment of cognitive disorders in MS, this review aims to motivate the necessity of early diagnosis and complex therapeutic approach to these disturbances in order to reduce the social burden of the disease.
Reference46 articles.
1. Cognitive impairment in multiple sclerosis;Chiaravalloti;Lancet Neurol,2008
2. Information processing deficits in multiple sclerosis : a matter of complexity;Parmenter;J Int Neuropsychol Soc,2007
3. National Clinical Advisory Board of the National Multiple Sclerosis Society Treatment Recommendations for Physicians : Assessment and Management of Cognitive Impairment in Multiple Sclerosis Expert Opinion New York;Benedict;Paper,2008
4. Relevance of brain lesion location to cognition in relapsing multiple sclerosis;Rossi;PLoS ONE,2012
5. Vision and multiple sclerosis;Hickman;Mult Scler Rel Dis,2014
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献